GLPGF News and Press, Galapagos Genomics Ord From 07/30/19

Source: Barron's Gilead ( GILD ) reports Q2 earnings July 30th. Analysts expect revenue of $5.51 billion and EPS of $1.72. The revenue estimate implies 4% growth sequentially. Investors should focus on the following key items: HCV Could Show Signs Of Life Gilead has experienced a ste...

Introduction From Spain last week to Scandinavia today. Whereas we discussed Fluidra’s ( OTC:FLUIF ) dominant position in the pool and wellness sector last week, in this week’s edition of Focus on Europe we are heading north to check up on Norsk Hydro ( OTCQX:NHYDY )...